@article{1cd92b1514d041ff83ba44bef6ea1c6a,
title = "ASNC/SNMMI Model Coverage Policy: Myocardial sympathetic innervation imaging: Iodine-123 meta-iodobenzylguanidine ((123)I-mIBG)",
author = "Sciammarella, {M. G.} and M. Gerson and Buxton, {A. E.} and Bartley, {S. C.} and R. Doukky and Merlino, {D. A.} and S. Tandon and R. Thompson and Travin, {M. I.}",
note = "Funding Information: Dr. M. I. Travin reports he is retained on Speakers{\textquoteright} Bureau by GE Healthcare. Dr. A. E. Buxton reports research grants from Biosense-Webster. Dr. A. E. Buxton has also received support for an investigator initiated study from Medtronic. Dr. R. Doukky reports an investigator initiated grant from Astellas Pharmaceuticals. He also serves on an advisory board for Astellas. D. A. Merlino is a consultant for the American Society of Nuclear Cardiology, the Society of Nuclear Medicine and Molecular Imaging, Bracco, the United Pharmacy Partners, and CIS-US now Pharmalucence. Other authors have reported nothing to disclose in relation to this topic and review.",
year = "2015",
month = aug,
day = "1",
doi = "10.1007/s12350-015-0202-8",
language = "English (US)",
volume = "22",
pages = "804--811",
journal = "Journal of Nuclear Cardiology",
issn = "1071-3581",
publisher = "Springer New York",
number = "4",
}